Royalcare Super Speciality Hospitals
₹152▼5.00%(8.00)
About the company
Royal Care Super Specialty Hospital is one of Coimbatore's leading healthcare institutions, known for delivering high-quality, patient-focused medical care. Established on May 1, 2015, the hospital began its journey as a 50-bed multi-specialty hospital with a vision to provide advanced healthcare services supported by modern technology, experienced medical professionals, and compassionate patient care.
Within a short period, Royal Care earned the trust of patients and referring doctors across western Tamil Nadu through its commitment to clinical excellence, accurate diagnosis, and personalized treatment. The growing demand for its services led to a significant expansion, transforming the hospital into a comprehensive tertiary care center capable of handling complex medical and surgical cases across multiple specialties.
Fundamentals
Valuation
| Metric | Value |
|---|---|
| 52 week high | ₹160 |
| 52 week low | ₹125 |
| P/B ratio | 9.21 |
| Debt to equity | 1.34 |
| ROE (%) | 4.72% |
| Book value | ₹17.37 |
| Face value | ₹10 |
52 week high
52 week low
P/B ratio
Debt
Equity
ROE (%)
| Metric | Value |
|---|---|
| 52 week high | ₹160 |
| 52 week low | ₹125 |
| P/B ratio | 9.21 |
| Debt | 57.3% of capital |
| Equity | 42.7% of capital |
| ROE (%) | 4.72% |
Registry
| Metric | Value |
|---|---|
| PAN number | AAGCR1968R |
| ISIN number | INE02C801010 |
Figures in cr ·
Financials
| P&L Statement | 2025Latest | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | 352 | 333 | 305 | 301 | 221 |
| EBITDA | 52 | 67 | 61 | 68 | 55 |
| OPM | 14.77 | 20.12 | 20 | 22.59 | 24.89 |
| PBT | 16 | 24 | 16 | 21 | 4 |
| PAT | 15 | 24 | 16 | 21 | 4 |
| EPS | 0.8 | 1.4 | 0.97 | 1.28 | 0.24 |
Shareholding Pattern
Promoters
Others
| Holder | Percentage |
|---|---|
| Promoters | 15.39% |
| Others | 84.61% |
Leadership
| Name | Role | Experience | |
|---|---|---|---|
| Dr. K. Madeswaran | Chairman & MD | 25+ yrs experience | — |
| Dr. K. Chockalingam | Director | 25+ yrs experience | — |
| Sri. T.Balachander | Director & CFO | 25+ yrs experience | — |
Frequently asked questions
Common questions on Royalcare Super Speciality Hospitals—tap a row to read the answer.
Q.1What is Royal Care Super Specialty Hospital?
Royal Care Super Specialty Hospital is a healthcare provider based in Coimbatore, Tamil Nadu, offering multi-specialty and tertiary care medical services. Since its establishment in 2015, the hospital has expanded its infrastructure and healthcare capabilities to serve patients across western Tamil Nadu with advanced diagnostics, specialized treatments, and comprehensive medical care.
Q.2Is Royal Care Super Specialty Hospital a listed or an unlisted company?
Royal Care Super Specialty Hospital is an unlisted company, meaning its shares are not traded on the National Stock Exchange (NSE) or Bombay Stock Exchange (BSE). Investors interested in owning its shares must purchase them through the unlisted share market, subject to availability.
Q.3How can I buy Royal Care Super Specialty Hospital unlisted shares?
You can purchase Royal Care Super Specialty Hospital unlisted shares through the private unlisted market. The process generally includes completing KYC verification, confirming the latest share price and availability, making the payment, and receiving the shares directly into your Demat account through an off-market transfer. It's advisable to review the company's financial performance and valuation before investing.
Q.4. How can I sell Royal Care Super Specialty Hospital shares?
If you own Royal Care Super Specialty Hospital shares, you can sell them through the unlisted market by finding an interested buyer. Once both parties agree on the price, the shares are transferred from the seller's Demat account to the buyer's account, and the payment is settled as per the agreed terms.
Q.5What is the minimum investment required for Royal Care Super Specialty Hospital shares?
There is no fixed minimum investment amount. The investment depends on the prevailing unlisted share price, the number of shares available, and the minimum quantity offered by the seller. Since prices in the unlisted market can fluctuate, investors should verify the latest details before making a purchase.
Q.6Is it legal to buy Royal Care Super Specialty Hospital unlisted shares in India?
Yes. Investing in Royal Care Super Specialty Hospital unlisted shares is legal in India when the transaction complies with applicable regulations. Shares should be transferred through a registered Demat account, and investors should ensure all documentation and payment procedures are completed properly.
Unlisted Trending shares
High-demand unlisted opportunities currently available for trade.
MARKET INSIGHTS & UPDATES
Read the latest updates, investment ideas, and market insights designed to help investors better understand unlisted and pre-IPO opportunities.

Muthoot FinCorp Unlisted Shares: Q1FY27 Profit Surges to ₹705 Cr | Fundamentals & IPO
Muthoot FinCorp's Q1FY27 profit surged to ₹705.48 crore as the company moves toward a proposed ₹3,000-crore IPO. Here's a look at its financial performance, valuation metrics, asset quality and key fundamentals.

From Debt to Debt-Free: How API Holdings Used Thyrocare to Reshape Its Balance Sheet
API Holdings has repaid ₹1,050 crore of debt by monetising a 9.90% stake in Thyrocare while retaining 51.02% control. Here's how the move reshapes its balance sheet and what it means going forward.

Pre IPO Shares in India: Price, How to Buy & Complete Guide
Learn what Pre IPO Shares are, how their prices are determined, how to buy them in India, and what investors should check before investing in unlisted companies.

Unlisted Shares Price List India | Buy Pre IPO Shares Online
The Unlisted Shares Price List India helps investors track the latest prices of privately traded companies before they are listed on stock exchanges. This guide explains what Unlisted Shares and Pre IPO Shares are, how their prices are determined, and the factors that influence their valuation. It also covers the benefits, risks, taxation, and step-by-step process of buying unlisted shares in India. Additionally, the article highlights popular companies such as NSE India, OYO, API Holding (Pharm Easy), MSEI, Gamma Rotors, Zepto, Orbis Financial, and Motilal Oswal Home Finance, providing readers with a comprehensive understanding of India's growing pre-IPO market. Whether you're a new or experienced investor, this guide offers practical insights to help you make informed investment decisions.

NSE IPO Moves Closer: SEBI Approval Expected by Mid-August, Listing May Happen in September
The National Stock Exchange (NSE) IPO is moving closer to listing, with SEBI's approval for the IPO draft expected by mid-August 2026, according to NDTV Profit sources. If the remaining regulatory process is completed on time, NSE could be listed in September 2026, subject to final approvals and market conditions. A key development is the expected final settlement order in the NSE co-location case, with the settlement amount likely to exceed ₹1,400 crore. Meanwhile, NSE has reportedly begun domestic and international investor roadshows as part of its IPO preparations. While these updates indicate strong momentum toward the IPO, the final timeline remains subject to SEBI approval and official announcements.

NCDEX Launches 'Nidhi' Mutual Fund Platform: A New Chapter in India's Financial Inclusion Journey
NCDEX has launched the 'Nidhi' Mutual Fund Platform, marking a significant step toward expanding financial inclusion across rural and semi-urban India. The platform aims to simplify mutual fund investments by leveraging NCDEX's extensive FPO and agri-network, making investment opportunities more accessible to underserved communities. With six leading Asset Management Companies (AMCs) onboard at launch, the initiative seeks to encourage wider participation in India's mutual fund ecosystem and promote long-term wealth creation. Discover the key features, benefits, and potential impact of the NCDEX Nidhi Mutual Fund Platform, and learn how this strategic move strengthens NCDEX's presence beyond commodity markets while supporting the growth of India's financial ecosystem.
